Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
04/15/14 GlaxoSmithKline (GSK) Tanzeum for Diabetes Mellitus, Type II Subscribers Only Subscribers Only     Subscribers Only
04/14/14 Boehringer Empagliflozin/Linagliptin for Diabetes Mellitus, Type II Subscribers Only Subscribers Only     Subscribers Only
04/14/14 Lexicon Pharmaceuticals (LXRX) LX4211 for Diabetes Mellitus, Type I Subscribers Only Subscribers Only     Subscribers Only
04/14/14 Cytos (CSBTF) CYT003-QbG10 for Asthma Subscribers Only Subscribers Only     Subscribers Only
04/12/14 Gilead (GILD) Sofosbuvir/Ledipasvir FDC for Hepatitis C (HCV) (Antiviral) Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
04/16/14 Subscribers Only Subscribers Only Patent - Expiration
04/16/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement